- Home
- Publications
- Publication Search
- Publication Details
Title
How to treat severe Acinetobacter baumannii infections
Authors
Keywords
-
Journal
CURRENT OPINION IN INFECTIOUS DISEASES
Volume 36, Issue 6, Pages 596-608
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-11-06
DOI
10.1097/qco.0000000000000974
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Epidemiology, Treatment, and Prognostic Factors of Hospital-Acquired Pneumonia Caused by the Extensively Drug-Resistant Acinetobacter Baumannii
- (2023) Changquan Fang et al. Clinical Laboratory
- Biological Properties of 12 Newly Isolated Acinetobacter baumannii-Specific Bacteriophages
- (2023) Natalia Bagińska et al. Viruses-Basel
- Characterisation and sequencing of the novel phage Abp95, which is effective against multi-genotypes of carbapenem-resistant Acinetobacter baumannii
- (2023) Li Huang et al. Scientific Reports
- PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens
- (2023) Chad W. Euler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator‐associated pneumonia: An open‐label randomized controlled trial
- (2023) Atousa Hakamifard et al. Clinical Respiratory Journal
- Incidence, mortality, and risk factors associated with carbapenem‐resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation
- (2023) Eun‐Ki Min et al. CLINICAL TRANSPLANTATION
- Acinetobacter baumannii Bacteriophage: Progress in Isolation, Genome Sequencing, Preclinical Research, and Clinical Application
- (2023) Yanqi Li et al. CURRENT MICROBIOLOGY
- In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study
- (2023) Irene Galani et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Assessing Acinetobacter baumannii virulence and treatment with a bacteriophage using zebrafish embryos
- (2023) Sofia Neto et al. FASEB JOURNAL
- The prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: review of the evidence
- (2023) Marin Kollef et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ukraine war and antimicrobial resistance
- (2023) Nicola Petrosillo et al. LANCET INFECTIOUS DISEASES
- Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022
- (2023) Oskar Ljungquist et al. LANCET INFECTIOUS DISEASES
- Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis
- (2023) Fatemeh Sodeifian et al. Microbial Drug Resistance
- Acinetobacter Baumannii Phages: Past, Present and Future
- (2023) Qihang Tu et al. Viruses-Basel
- Characterization of Virulent T4-Like Acinetobacter baumannii Bacteriophages DLP1 and DLP2
- (2023) Danielle L. Peters et al. Viruses-Basel
- Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
- (2023) Pierluigi Viale et al. Annals of Intensive Care
- Synergistic Antibacterial Effect of Phage pB3074 in Combination with Antibiotics Targeting Cell Wall against Multidrug-Resistant Acinetobacter baumannii In Vitro and Ex Vivo
- (2023) Jun Luo et al. Microbiology Spectrum
- Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case Series Study
- (2023) Stelios F. Assimakopoulos et al. Pathogens
- Isolation and characterization of three novel Acinetobacter baumannii phages from Beninese hospital wastewater
- (2023) Anna Kolsi et al. ARCHIVES OF VIROLOGY
- Sulbactam/Durlobactam: First Approval
- (2023) Susan J. Keam DRUGS
- Geographical patterns of in vitro susceptibilities to tigecycline and colistin among worldwide isolates of Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016–2021
- (2023) Jiun-Ling Wang et al. International Journal of Antimicrobial Agents
- Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis
- (2023) Xiaoyu Zhang et al. JOURNAL OF CRITICAL CARE
- The effect of phage-antibiotic combination strategy on multidrug-resistant Acinetobacter baumannii biofilms
- (2023) Hilal Basak Erol et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Contribution of different mechanisms to aminoglycoside resistance in clinical isolates of Acinetobacter baumannii
- (2023) Neveen M. Saleh et al. MICROBIAL PATHOGENESIS
- Characterization of a novel and active temperate phage vB_AbaM_ABMM1 with antibacterial activity against Acinetobacter baumannii infection
- (2023) Meity Mardiana et al. Scientific Reports
- Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections
- (2022) Giovanni Satta et al. CURRENT OPINION IN PULMONARY MEDICINE
- Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter baumannii-Associated Skin and Soft Tissue Infections
- (2022) Phitchayapak Wintachai et al. Viruses-Basel
- Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii
- (2022) Phitchayapak Wintachai et al. Scientific Reports
- The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage
- (2022) Behnam Sisakhtpour et al. Annals of Clinical Microbiology and Antimicrobials
- Plasmid-Mediated Fluoroquinolone Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii
- (2022) P. V. Geetha et al. Journal of Laboratory Physicians
- Efficacy of Eravacycline Versus Best Previously Available Therapy for Adults With Pneumonia Due to Difficult-to-Treat Resistant (DTR) Acinetobacter baumannii
- (2022) Courtney J. Scott et al. ANNALS OF PHARMACOTHERAPY
- Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
- (2022) Marco Falcone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biological characterization and genomic analysis of Acinetobacter baumannii phage BUCT628
- (2022) Yinuo Zhu et al. ARCHIVES OF VIROLOGY
- Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections
- (2022) Zhenhua Qian et al. Biomed Research International
- Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii
- (2022) Yun Li et al. Journal of Global Antimicrobial Resistance
- Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study
- (2022) Fernando L. Gordillo Altamirano et al. EBioMedicine
- Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
- (2022) Taylor Abbey et al. Microbiology Spectrum
- Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy
- (2022) Mei Liu et al. Nature Communications
- Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018)
- (2022) H Seifert et al. Journal of Global Antimicrobial Resistance
- Durlobactam in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections: A Systematic Review
- (2022) Guido Granata et al. Journal of Clinical Medicine
- Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii In Vitro and In Vivo
- (2022) Jun Luo et al. Microbiology Spectrum
- In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii - calcoaceticus Complex Collected from 2016 to 2021
- (2022) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii-induced infective endocarditis: new insights into pathophysiology and antibiotic resistance mechanisms
- (2022) Innocent Afeke et al. Future Microbiology
- Antibacterial spectrum of cefiderocol
- (2022) Desirée Gijón Cordero et al. Revista Espanola de Quimioterapia
- Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
- (2022) Sara Alosaimy et al. Microbiology Spectrum
- A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Pneumonia: An Interim Analysis
- (2022) Chutchawan Ungthammakhun et al. Antibiotics-Basel
- In Vitro Activity of Sulbactam–Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy
- (2022) Bernardetta Segatore et al. Antibiotics-Basel
- Recent Progress in Phage Therapy to Modulate Multidrug-Resistant Acinetobacter baumannii, including in Human and Poultry
- (2022) Yan Zhang et al. Antibiotics-Basel
- Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections
- (2022) Matteo Bassetti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
- (2022) Rujipas Sirijatuphat et al. Antibiotics-Basel
- Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii
- (2022) Yujing Tan et al. Bioengineering
- Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
- (2022) Panagiotis Zagaliotis et al. Pathogens and Immunity
- Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii
- (2021) Jiaqi Cheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteriophage Therapy of Bacterial Infections: The Rediscovered Frontier
- (2021) Nejat Düzgüneş et al. Pharmaceuticals
- Rescuing the Last-Line Polymyxins: Achievements and Challenges
- (2021) Sue C. Nang et al. PHARMACOLOGICAL REVIEWS
- Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease
- (2021) Xin Tan et al. Frontiers in Cellular and Infection Microbiology
- Overexpression of Efflux Pumps, Mutations in the Pumps’ Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study
- (2021) Subhasree Roy et al. Frontiers in Microbiology
- Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients
- (2021) Nannan Wu et al. Emerging Microbes & Infections
- Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.
- (2021) Cristina Lasarte-Monterrubio et al. Antibiotics-Basel
- Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem–Resistant Acinetobacter baumannii
- (2021) Ozioma F. Nwabor et al. Pharmaceuticals
- Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
- (2021) Jun-Ping Qin et al. Scientific Reports
- New Perspectives on Antimicrobial Agents: Cefiderocol
- (2021) Erin K. McCreary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections
- (2021) Vincent Trebosc et al. DRUG DISCOVERY TODAY
- Genetic factors involved in fosfomycin resistance of multidrug-resistant Acinetobacter baumannii
- (2021) Gleice C. Leite et al. INFECTION GENETICS AND EVOLUTION
- Development of thermosensitive hydrogel wound dressing containing Acinetobacter baumannii phage against wound infections
- (2021) Wei Yan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
- (2021) Po-Yu Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Bacteriophage therapeutics to confront multidrug‐resistant Acinetobacter baumannii ‐ a global health menace
- (2021) Sandhya Rai et al. Environmental Microbiology Reports
- In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
- (2021) Jacinda C. Abdul-Mutakabbir et al. Antibiotics-Basel
- Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy
- (2021) Sohail Rao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The role of Gram-negative bacteria in skin and soft tissue infections
- (2021) Alessandro Russo et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection
- (2021) Sandra-Maria Wienhold et al. Viruses-Basel
- Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019
- (2021) Michael A. Pfaller et al. Journal of Global Antimicrobial Resistance
- In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
- (2021) Bosul Lee et al. mSphere
- Treatment of multidrug-resistant Gram-negative skin and soft tissue infections
- (2020) Jean-Francois Jabbour et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Safety, Pharmacokinetics, and Drug:Drug Interaction Potential of Intravenous Durlobactam, a β-lactamase Inhibitor, in Healthy Subjects
- (2020) Jason D. Lickliter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
- (2020) Amir Nutman et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017–2018
- (2020) Dong Dong et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals
- (2020) Alejandro Iregui et al. Microbial Drug Resistance
- Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials
- (2020) Majid Taati Moghadam et al. Drug Design Development and Therapy
- In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
- (2020) Vincent Trebosc et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Pharmacodynamic Analysis of Meropenem and Fosfomycin Combination Against Carbapenem-Resistant Acinetobacter baumannii in Patients with Normal Renal Clearance: Can It Be a Treatment Option?
- (2020) Sazlyna Mohd Sazlly Lim et al. Microbial Drug Resistance
- Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2020) Jiating Liu et al. Journal of Global Antimicrobial Resistance
- Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
- (2020) Hyo-Ju Son et al. Open Forum Infectious Diseases
- Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study
- (2020) Alessandro Russo et al. Infectious Diseases and Therapy
- Minocycline alone and in combination with polymyxin B, meropenem, and sulbactam against carbapenem- susceptible and resistant Acinetobacter baumannii in in vitro pharmacodynamic model
- (2020) Maya Beganovic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice
- (2020) Katja Becker et al. CLINICAL MICROBIOLOGY AND INFECTION
- Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection
- (2020) Misung Kim et al. Virulence
- Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination
- (2019) Ran Nir-Paz et al. CLINICAL INFECTIOUS DISEASES
- Multicentre evaluation of the new ETEST gradient diffusion method for piperacillin-tazobactam susceptibility testing of Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii complex
- (2019) Sergio García-Fernandez et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
- (2019) Michael S Niederman et al. LANCET INFECTIOUS DISEASES
- Postoperative multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intravenous doxycycline and intraventricular gentamicin: A case report
- (2019) Xia Wu et al. World Journal of Clinical Cases
- Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model
- (2018) Anthony D. Kang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study
- (2018) Shuangshuang Yang et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates
- (2018) Uthaibhorn Singkham-in et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii
- (2018) Youfa Qin et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity
- (2018) Mohan Ju et al. Journal of Thoracic Disease
- Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature
- (2018) David P Serota et al. Open Forum Infectious Diseases
- Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
- (2018) Muhammad Asif et al. Infection and Drug Resistance
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial
- (2018) Yaakov Dickstein et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii meningitis in children: a case series and literature review
- (2018) Jiying Xiao et al. INFECTION
- In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
- (2018) Mario Juhas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Functional analysis and anti-virulent properties of a new depolymerase from a myovirus that infects Acinetobacter baumannii capsule K45
- (2018) Hugo Oliveira et al. JOURNAL OF VIROLOGY
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- Colistin Monotherapy Versus Colistin and Rifampin Combination Therapy in Pneumonia Caused by Colistin-resistant Acinetobacter baumannii: A Randomized Controlled Trial
- (2018) Hye Jung Park et al. Journal of Global Antimicrobial Resistance
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: a nationwide proficiency study
- (2017) Felipe Fernández-Cuenca et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: A systematic review and meta-analysis
- (2017) Haojun Chen et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Activity of levofloxacin in combination with colistin against Acinetobacter baumannii : In vitro and in a Galleria mellonella model
- (2017) Wenjuan Wei et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Rediscovering the octapeptins
- (2017) Tony Velkov et al. NATURAL PRODUCT REPORTS
- Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections
- (2016) E. Durante-Mangoni et al. CLINICAL MICROBIOLOGY AND INFECTION
- Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality
- (2016) José Garnacho-Montero et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
- (2016) Lindsey M. Weiner et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Endocarditis due to Acinetobacter baumannii
- (2016) Mauro Sturiale et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fosfomycin resistance inAcinetobacter baumanniiis mediated by efflux through a major facilitator superfamily (MFS) transporter—AbaF
- (2016) Atin Sharma et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan
- (2016) Jyh-You Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Vertebral Osteomyelitis and Acinetobacter Spp. Paravertebral Soft Tissue Infection in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease
- (2016) Pandiarajan Vignesh et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
- (2016) Bing Fan et al. PLoS One
- Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
- (2015) William F. Penwell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Phage Lysin Capable of Killing the Multidrug-Resistant Gram-Negative Bacterium Acinetobacter baumannii in a Mouse Bacteremia Model
- (2015) Rolf Lood et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
- (2015) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Secular trends inAcinetobacter baumanniiresistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study
- (2015) Marya D. Zilberberg et al. Journal of Hospital Medicine
- Community-acquired Acinetobacter baumannii pneumonia
- (2015) K. Bachoumas et al. MEDECINE ET MALADIES INFECTIEUSES
- Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia
- (2015) Gul R. Yilmaz et al. Journal of Infection in Developing Countries
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options
- (2014) Mariana Castanheira et al. CLINICAL INFECTIOUS DISEASES
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2014) M. Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: Sensitivity to antibiotics and risk factors
- (2013) Zorana Djordjevic et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
- (2013) Haiqing Chu et al. Brazilian Journal of Infectious Diseases
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors
- (2013) Anis Chaari et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- (2013) L. Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-SusceptibleAcinetobacter baumannii
- (2013) Hee Kyoung Choi et al. YONSEI MEDICAL JOURNAL
- In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii
- (2013) YAJUN ZHANG et al. Experimental and Therapeutic Medicine
- Can ampicillin/sulbactam resistance in Acinetobacter baumannii be predicted accurately by disk diffusion?
- (2013) Giselle Fukita Viana et al. Journal of Global Antimicrobial Resistance
- Novel Mechanism for Fluoroquinolone Resistance in Acinetobacter baumannii
- (2012) Sunil D. Saroj et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
- (2012) D. F. Florescu et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China
- (2012) C. Peng et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Identification of a novel insertion sequence element associated with carbapenem resistance and the development of fluoroquinolone resistance in Acinetobacter radioresistens
- (2012) Paul G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
- (2012) Song Yee Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection
- (2012) Astra Vitkauskiene et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predictability of Doripenem Susceptibility inAcinetobacter baumanniiIsolates Based on Other Carbapenem Susceptibilities andblaOXAGene Status
- (2010) John S Esterly et al. PHARMACOTHERAPY
- Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors
- (2010) Murat Dizbay et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Increase of Ceftazidime- and Fluoroquinolone-ResistantKlebsiella pneumoniaeand Imipenem-ResistantAcinetobacterspp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007
- (2010) Kyungwon Lee et al. YONSEI MEDICAL JOURNAL
- Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)
- (2009) Paul R. Rhomberg et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature
- (2009) Antonio Cascio et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Management of meningitis due to antibiotic-resistant Acinetobacter species
- (2009) Baek-Nam Kim et al. LANCET INFECTIOUS DISEASES
- Severe community-acquiredAcinetobacter baumanniipneumonia: An emerging highly lethal infectious disease in the Asia-Pacific
- (2009) Catherine W.M. ONG et al. RESPIROLOGY
- Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex
- (2008) E. Tacconelli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
- (2008) M. S. Oliveira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review
- (2008) V. Krol et al. JOURNAL OF HOSPITAL INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search